(Q58842339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lisardo Bosca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Marta Casado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Belén Mollá

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rosa Roy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Amalia Fernández-Martínez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Carme Cucarella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Paloma Martín-Sanz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

631-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

Prostaglandin endoperoxide synthase: regulation of enzyme expression

26 December 2019

cites work

1 reference

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

21 January 2018

1 reference

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

7 January 2021

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

1 reference

7 January 2021

Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells

1 reference

7 January 2021

Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.

1 reference

7 January 2021

Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines.

1 reference

7 January 2021

Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy.

1 reference

7 January 2021

Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins

1 reference

7 January 2021

Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes.

1 reference

7 January 2021

Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.

1 reference

7 January 2021

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

1 reference

7 January 2021

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

7 January 2021

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins

1 reference

7 January 2021

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

1 reference

7 January 2021

Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma

1 reference

7 January 2021

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

1 reference

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

7 January 2021

Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis

1 reference

7 January 2021

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

1 reference

7 January 2021

Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer

1 reference

7 January 2021

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

1 reference

7 January 2021

Effect of a rhodium complex on alterations of hepatic function in thioacetamide-induced hyperplastic noduligenesis in rats.

1 reference

7 January 2021

Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decrease

1 reference

7 January 2021

Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?

1 reference

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

7 January 2021

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

7 January 2021

Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis

1 reference

7 January 2021

Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice.

1 reference

7 January 2021

Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells.

1 reference

7 January 2021

Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation

1 reference

7 January 2021

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17326157%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference